Cited by 114Alzheimer's disease research and treatmentsDementia and Cognitive Impairment ResearchIntracerebral and Subarachnoid Hemorrhage Research

Dense-Core Senile Plaques in the Flemish Variant of Alzheimer's Disease Are Vasocentric

Open access
Kumar-Singh, Samir, Cras, Patrick, Wang, Rong, Kros, John M., van Swieten, Johan, Lübke, Ursula, Ceuterick, Chantal, Serneels, Sally +6 more·2002·The American Journal of Pathology

Abstract

Alzheimer's disease (AD) is characterized by deposition of beta-amyloid (Abeta) in diffuse and senile plaques, and variably in vessels. Mutations in the Abeta-encoding region of the amyloid precursor protein (APP) gene are frequently associated with very severe forms of vascular Abeta deposition, sometimes also accompanied by AD pathology. We earlier described a Flemish APP (A692G) mutation causing a form of early-onset AD with a prominent cerebral amyloid angiopathy and unusually large senile plaque cores. The pathogenic basis of Flemish AD is unknown. By image and mass spectrometric Abeta analyses, we demonstrated that in contrast to other familial AD cases with predominant brain Abeta42, Flemish AD patients predominantly deposit Abeta40. On serial histological section analysis we further showed that the neuritic senile plaques in APP692 brains were centered on vessels. Of a total of 2400 senile plaque cores studied from various brain regions from three patients, 68% enclosed a vessel, whereas the remainder were associated with vascular walls. These observations were confirmed by electron microscopy coupled with examination of serial semi-thin plastic sections, as well as three-dimensional observations by confocal microscopy. Diffuse plaques did not associate with vessels, or with neuritic or inflammatory pathology. Together with earlier in vitro data on APP692, our analyses suggest that the altered biological properties of the Flemish APP and Abeta facilitate progressive A…

Integrity signals

Registry

Crossref · 10.1016/s0002-9440(10)64207-1

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Individuals with vasculotropic APP mutations within Aβ 21-23 residues, including Dutch, Arctic, Flemish, Iowa, and Italian mutations, develop prominent CAA causing extensive cerebrovascular pathology.

    “Individuals with 'vasculotropic' APP mutations within A 𝛃 21-23 residues including Dutch (E693Q), Arctic (E693G), Flemish (A692G), Iowa (D694N), and Italian (E693K) mutation (49, 211, 335, 356, 526, 674) develop prominent CAA (238, 640) causing extensive cerebrovascular pathology.”

    From Blood-Brain Barrier: From Physiology to Disease and Back (2019) · cites this paper as [335]

The citation lists haven’t been fetched yet

References 78 · Cited by 114

Authors
Kumar-Singh, S., Cras, P., Wang, R., Kros, J. M., van Swieten, J., Lübke, U., Ceuterick, C., Serneels, S., Vennekens, K., Timmermans, J.-P., Van Marck, E., Martin, J.-J., van Duijn, C. M., & Van Broeckhoven, C.
Affiliations
  • University of Antwerp (BE)
  • Icahn School of Medicine at Mount Sinai (US)
  • Erasmus MC (NL)
Venue
The American Journal of Pathology
Publisher
Elsevier BV
Published
2002-08
Volume
161
Issue
2
Pages
507-520
ISSN
0002-9440 (ISSN-L)
OpenAlex
W2140112364
Cited by
114
References
78
Citations by year
2026: 2 · 2025: 1 · 2024: 6 · 2023: 3 · 2022: 5 · 2021: 4 · 2020: 5 · 2019: 4 · 2018: 5 · 2017: 1 · 2016: 7 · 2015: 6 · 2014: 3 · 2013: 3 · 2012: 3
FWCI
3.80
Type
journal article
Language
en
Open access
Locations
  • American Journal Of Pathology (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • EUR Research Repository (Erasmus University Rotterdam) (publishedVersion, other-oa)
  • EUR Research Repository (Erasmus University Rotterdam) (submittedVersion, other-oa)
  • RePub (Erasmus University Rotterdam) (submittedVersion, other-oa)
Funders
  • Fonds De La Recherche Scientifique - FNRS
  • National Institutes of Health (AG10491)
Topics
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
  • Health Sciences › Medicine › Neurology › Intracerebral and Subarachnoid Hemorrhage Research
Keywords
Alzheimer's disease, amyloid precursor protein, amyloid plaques, cerebral amyloid angiopathy, amyloid-beta deposition, Aβ40, amyloid-beta 42, neuritic plaques, diffuse plaques, familial Alzheimer's disease, early-onset Alzheimer's disease
MeSH terms
Alzheimer Disease, Amino Acid Sequence, Brain, Cerebrovascular Circulation, Female, Humans, Male, Molecular Sequence Data, Mutation, Pedigree, Amyloid beta-Protein Precursor, Plaque, Amyloid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review